Select respiratory deals by biopharma companies by value 2020

Select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by value (in million U.S. dollars)

Leading respiratory deals by biopharma companies worldwide in 2020, by value

Last update:

Sep 22, 2021

Author:

��ƽ�� Research Department

Region:

Worldwide

Survey time period:

From 01/01/2020 to 31/12/2020

In 2020, Oneness Biotech and LEO Pharma partnered on a 570 million U.S. dollar respiratory diseases deal, while Moderna and Vertex partnered on a 380 million U.S. dollar respiratory deal in the same year. This statistic illustrates select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by deal value.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by value (in million U.S. dollars)

Get in touch with us for additional information

��ƽ��